Quantum Computing (QUBT) Stock: What to Expect from Earnings on Monday

TLDR

Quantum Computing (QUBT) reports Q4 FY25 earnings on March 2, 2026
Wall Street expects a loss of $0.02 per share, down from a $0.47 loss a year ago
Revenue is forecast at $390K, up from $62K in Q4 2024
The stock fell 8.4% on February 27, trading below both its 50-day and 200-day moving averages
Options traders are pricing in a 14.05% move in either direction post-earnings

Quantum Computing Inc. is set to report its Q4 FY25 results on Monday, March 2, 2026. The stock has had a rough stretch heading into the report, dropping 8.4% on February 27 to close at $8.278.

Quantum Computing, Inc., QUBT

Trading volume that day came in at around 3.37 million — roughly 78% below its average session volume of 15 million. That kind of low-volume sell-off can reflect thin conviction, but it doesn’t tell the whole story.

The stock is now sitting below both its 50-day moving average of $10.35 and its 200-day moving average of $13.70. Over the past year, QUBT is still up more than 39%, driven largely by investor interest in its photonic technology.

Wall Street is expecting a loss of $0.02 per share for Q4 2025. That’s a sharp improvement from the $0.47 per share loss reported in the same quarter a year ago.

Revenue expectations are set at $390K, compared to just $62K in Q4 2024. While the numbers are small, the direction of travel is what analysts are watching.

Luminar Acquisition in Focus

One of the bigger storylines heading into the call is the company’s $110 million all-cash acquisition of Luminar Semiconductor Inc., previously owned by Luminar Technologies. The deal is designed to give QUBT more control over its own technology stack and bring it closer to generating steady revenue.

Investors on the earnings call will be listening for updates on chip production timelines, order delivery progress, and any early signs of revenue momentum from the deal.

Analyst Targets Have Been Cut

Analyst sentiment is a mixed bag. Lake Street’s Max Michaelis kept a Buy rating on the stock but lowered his price target from $24 to $16 — still implying around 77% upside from current levels.

Ascendiant Capital Markets also trimmed its target, from $40 down to $25, while keeping a Buy rating. On the more cautious side, Wedbush initiated coverage with a Neutral rating and a $12 target, and Cantor Fitzgerald reiterated a Neutral with a $15 target.

Rosenblatt Securities started coverage in January with a Buy and a $22 target. Overall, the consensus sits at Moderate Buy, with one Strong Buy, two Buys, two Holds, and one Sell among tracked analysts.

The average price target across the group is $18.00, which would represent roughly 99% upside from where the stock was trading on February 27.

QUBT carries a beta of 3.44, meaning it moves sharply relative to the broader market. Its market cap sits at approximately $1.83 billion, and the P/E ratio is negative at -13.40, reflecting its pre-profitability status.

Insiders own 19.3% of the company. COO Milan Begliarbekov sold 2,860 shares on January 7 at $11.85 each, reducing his position by about 10.55%. Institutional ownership remains low at just 4.26%.

Options traders are pricing in a move of about 14.05% in either direction following the earnings release.

Q4 FY25 results are due before markets open on March 2, 2026.